Does Mounjaro List Headaches as a Side Effect?
Yes, headaches are a reported side effect of Mounjaro (tirzepatide), an injectable GLP-1/GIP receptor agonist for type 2 diabetes and weight management. Clinical trial data and post-marketing reports confirm headaches occur in some patients, typically mild to moderate.[1][2]
How Common Are Headaches on Mounjaro?
In pivotal trials like SURPASS, headaches affected 5-14% of patients on Mounjaro doses (5-15 mg weekly), compared to 6-10% on placebo or comparators like semaglutide. Frequency rises slightly with higher doses but resolves for most without stopping treatment.[1][3] Real-world data from patient forums and FDA adverse event reports (FAERS) show headaches in about 2-5% of submissions, often early in treatment.[2]
Why Do Headaches Happen with Mounjaro?
Headaches likely stem from dehydration (due to nausea/vomiting), blood sugar fluctuations, or vascular effects from GLP-1/GIP action on the brain's appetite centers. They peak in the first 4-8 weeks as the body adjusts, then often fade.[1][4]
How Long Do Mounjaro Headaches Last?
Most last hours to days per episode, improving within 1-4 weeks of starting. Persistent cases beyond 8 weeks warrant medical review for underlying issues like low blood sugar or tension.[3][4]
What Helps Mounjaro Headaches?
- Stay hydrated (aim for 8-10 glasses water daily).
- Take over-the-counter pain relievers like acetaminophen (avoid NSAIDs if GI issues).
- Dose timing: Inject earlier in the day if headaches follow shots.
- Slow titration: Start low and increase gradually per prescribing info.
Consult a doctor before changes; they may adjust dose or check for interactions.[4][5]
When Should You Worry About Headaches on Mounjaro?
Seek care if headaches are severe, sudden, with vision changes, neck stiffness, or confusion—these could signal rare issues like dehydration, migraine triggers, or pancreatitis. Not linked to strokes in trials, but monitor blood pressure.[1][2]
Do Other GLP-1 Drugs Like Ozempic or Wegovy Cause Headaches Too?
Yes, similar profile: Ozempic (semaglutide) reports headaches in 7-14% of users; Wegovy in 10-15%. Mounjaro's dual mechanism may slightly elevate risk vs. single-GLP-1s, but all are dose-dependent and transient.[1][3]
[1]: Mounjaro Prescribing Information (FDA)
[2]: FDA FAERS Database
[3]: SURPASS Clinical Trials (NEJM)
[4]: Eli Lilly Mounjaro Safety Info
[5]: Drugs.com Mounjaro Side Effects